نتائج البحث - "Eleonora Iuliano"

1

Polymorphic Variants in NR 1I3 and UGT 2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case‐Control Study

المؤلفون: Francesca Scionti, Fernanda Fabiani, Daniele Caracciolo, Grazia Arpino, Pierosandro Tagliaferri, Teresa Galeano, Nicoletta Staropoli, Mario Cannataro, Mariamena Arbitrio, Pierfrancesco Tassone, Emanuela Altomare, Maria Teresa Di Martino, Daniele Santini, Francesco Grillone, Giuseppe Agapito, Eleonora Iuliano

المصدر: Clinical Pharmacology & Therapeutics. 106:422-431

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bc39ba6ef2c921fd1cc05027a393f48dTest
https://doi.org/10.1002/cpt.1391Test

2

Myositis/myasthenia after pembrolizumab in a bladder cancer patient with an autoimmunity-associated HLA: Immune–biological evaluation and case report

المؤلفون: Roberto Maisano, Giovanna Orizzonte, Giorgio Restifo, Pierpaolo Correale, Michele Caraglia, Vincenzo Dattola, Cirino Botta, Rita Agostino, Rita Emilena Saladino, Domenico Mazzacuva, Rocco Giannicola, Antonia Consuelo Falzea, Natale Daniele Calandruccio, Antonino Mafodda, Umberto Aguglia, Giovanna Bianco, Eleonora Iuliano, Vittoria Cianci

المساهمون: Botta, C., Agostino, R. M., Dattola, V., Cianci, V., Calandruccio, N. D., Bianco, G., Mafodda, A., Maisano, R., Iuliano, E., Orizzonte, G., Mazzacuva, D., Falzea, A. C., Saladino, R. E., Giannicola, R., Restifo, G., Aguglia, U., Caraglia, M., Correale, P., Botta C., Agostino R.M., Dattola V., Cianci V., Calandruccio N.D., Bianco G., Mafodda A., Maisano R., Iuliano E., Orizzonte G., Mazzacuva D., Falzea A.C., Saladino R.E., Giannicola R., Restifo G., Aguglia U., Caraglia M., Correale P.

المصدر: International Journal of Molecular Sciences, Vol 22, Iss 6246, p 6246 (2021)
International Journal of Molecular Sciences

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Case Report, Autoimmunity, Pembrolizumab, PD1-checkpoint inhibitors, medicine.disease_cause, 0302 clinical medicine, Antineoplastic Agents, Immunological, Biology (General), HLA Antigen, Myositi, PD1-checkpoint inhibitor, Spectroscopy, Myositis, General Medicine, Computer Science Applications, Myasthenia Gravi, Chemistry, Pyridostigmine, urothelial cancer, 030220 oncology & carcinogenesis, Urinary Bladder Neoplasm, Class-I/II HLA, Myasthenia, medicine.drug, Human, medicine.medical_specialty, QH301-705.5, Prognosi, Human leukocyte antigen, Antibodies, Monoclonal, Humanized, Catalysis, Inorganic Chemistry, 03 medical and health sciences, Internal medicine, medicine, Physical and Theoretical Chemistry, Adverse effect, Molecular Biology, QD1-999, Aged, business.industry, Organic Chemistry, Cancer, medicine.disease, Discontinuation, 030104 developmental biology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5f1730fa5ddbbe610ba6d945569661Test
http://hdl.handle.net/11591/462420Test

3

HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis

المساهمون: Correale, P., Saladino, R. E., Giannarelli, D., Sergi, A., Mazzei, M. A., Bianco, G., Giannicola, R., Iuliano, E., Forte, I. M., Calandruccio, N. D., Falzea, A. C., Strangio, A., Nardone, V., Pastina, P., Tini, P., Luce, A., Caraglia, M., Caracciolo, D., Mutti, L., Tassone, P., Pirtoli, L., Giordano, A., Tagliaferri, P.

المصدر: Cells
Volume 9
Issue 9
Cells, Vol 9, Iss 1964, p 1964 (2020)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_specialty, Bevacizumab, medicine.medical_treatment, Genes, MHC Class I, immune-related pneumoniti, immune-related pneumonitis, Article, PD-1/PD-L1 blockade, 03 medical and health sciences, 0302 clinical medicine, Cancer immunotherapy, Internal medicine, irAE, medicine, Humans, Lung cancer, lcsh:QH301-705.5, Immune Checkpoint Inhibitors, Pneumonitis, Retrospective Studies, cancer immunotherapy, business.industry, Melanoma, HLA-profile, General Medicine, Pneumonia, Middle Aged, medicine.disease, Immune checkpoint, Blockade, Radiation therapy, 030104 developmental biology, lcsh:Biology (General), 030220 oncology & carcinogenesis, irAEs, Female, Immunotherapy, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc9c929bb077dbc57de3cfcdd247b02Test
http://europepmc.org/articles/PMC7564884Test

4

Correlation of HLA-B*35 and DRB1*11 alleles with a high risk of interstitial aseptic pneumonitis in cancer patients receiving PD-1/PDL1 immune-checkpoint blockade

المصدر: Journal of Clinical Oncology. 38:e15094-e15094

مصطلحات موضوعية: Cancer Research, business.industry, Cancer, medicine.disease, Immune checkpoint, HLA-B, Blockade, Oncology, Immunology, Medicine, Aseptic processing, Allele, business, Pneumonitis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::158950d7652285895704d36e3f1f82c9Test
https://doi.org/10.1200/jco.2020.38.15_suppl.e15094Test

5

The Era of PARP inhibitors in ovarian cancer: 'Class Action' or not? A systematic review and meta-analysis

المؤلفون: Nicoletta Staropoli, Pierfrancesco Tassone, Vito Barbieri, Angela Salvino, Pierosandro Tagliaferri, Domenico Ciliberto, Teresa Del Giudice, Francesco Grillone, Antonio Russo, Maria Cucè, Eleonora Iuliano

المساهمون: Staropoli, Nicoletta, Ciliberto, Domenico, Del Giudice, Teresa, Iuliano, Eleonora, Cucè, Maria, Grillone, Francesco, Salvino, Angela, Barbieri, Vito, Russo, Antonio, Tassone, Pierfrancesco, Tagliaferri, Pierosandro

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce94b6b66d1bf4982c1662dd47dbf8acTest
http://hdl.handle.net/10447/298741Test

6

Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis

المؤلفون: Vito Barbieri, Serafino Conforti, Eleonora Iuliano, Pierosandro Tagliaferri, Maria Teresa Di Martino, Cirino Botta, Francesca Scionti, Pietro Hiram Guzzi, Mariamena Arbitrio, Mario Cannataro, Stefania Codispoti, Pierfrancesco Tassone, Emanuela Altomare, Giuseppe Agapito

المساهمون: Arbitrio M., Di Martino M.T., Barbieri V., Agapito G., Guzzi P.H., Botta C., Iuliano E., Scionti F., Altomare E., Codispoti S., Conforti S., Cannataro M., Tassone P., Tagliaferri P.

المصدر: Cancer chemotherapy and pharmacology 77 (2016): 205–209. doi:10.1007/s00280-015-2916-3
info:cnr-pdr/source/autori:Arbitrio M.; Di Martino M.T.; Barbieri V.; Agapito G.; Guzzi P.H.; Botta C.; Iuliano E.; Scionti F.; Altomare E.; Codispoti S.; Conforti S.; Cannataro M.; Tassone P.; Tagliaferri P./titolo:Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis/doi:10.1007%2Fs00280-015-2916-3/rivista:Cancer chemotherapy and pharmacology/anno:2016/pagina_da:205/pagina_a:209/intervallo_pagine:205–209/volume:77

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lung Neoplasms, genetic structures, Microarray, Pharmacology, Toxicology, Skin rash, 0302 clinical medicine, Non-small cell lung cancer, Carcinoma, Non-Small-Cell Lung, Genotype, Pharmacology (medical), Erlotinib Hydrochloride, Cholecalciferol, Oligonucleotide Array Sequence Analysis, Middle Aged, Erlotinib, 030220 oncology & carcinogenesis, Female, Drug Eruptions, medicine.drug, medicine.medical_specialty, Single-nucleotide polymorphism, Antineoplastic Agents, Polymorphism, Single Nucleotide, 03 medical and health sciences, Internal medicine, medicine, Humans, Lung cancer, Aged, Retrospective Studies, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase, Inflammation, business.industry, Microarray analysis techniques, Cancer, Single nucleotide polymorphisms, medicine.disease, Single nucleotide polymorphism, 030104 developmental biology, DMET, Quality of Life, business